| For: | Vasilev G, Kokudeva M, Siliogka E, Padilla N, Shumnalieva R, Della-Morte D, Ricordi C, Mihova A, Infante M, Velikova T. T helper 17 cells and interleukin-17 immunity in type 1 diabetes: From pathophysiology to targeted immunotherapies. World J Diabetes 2025; 16(4): 99936 [PMID: 40236846 DOI: 10.4239/wjd.v16.i4.99936] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i4/99936.htm |
| Number | Citing Articles |
| 1 |
Bidhayak Chakraborty, Sreenivasa Nayaka, Chandan A. Bhairappanavar, Gireesh Babu Kantli, Shashiraj Kariyellappa Nagaraja. Network pharmacology and molecular simulation insights into the anti-diabetic and anti-inflammatory mechanisms of Ricinus communis. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(5) doi: 10.1007/s00210-025-04827-z
|
| 2 |
Qi Tang, Li Zhou, Liwen Fan, Wei Zhang, Xixiang Tang, Donglan Zeng, Mei Li, Yanhua Zhu, Mengyin Cai, Jia Yuan, Zheng Chen, Song Guo Zheng, Yanming Chen. Safety and efficacy of human gingiva-derived mesenchymal stem cells in patients with type 1 diabetes: a double-blind, randomized, placebo-controlled, phase 1 trial. Signal Transduction and Targeted Therapy 2026; 11(1) doi: 10.1038/s41392-026-03021-8
|
| 3 |
Roha Asif, Ammara Khalid, Tolga Mercantepe, Aleksandra Klisic, Sana Rafaqat, Saira Rafaqat, Filiz Mercantepe. Role of Interleukins in Type 1 and Type 2 Diabetes. Diagnostics 2025; 15(15) doi: 10.3390/diagnostics15151906
|
| 4 |
Eiji Kawasaki. Fulminant and Slowly Progressive Type 1 Diabetes Associated with Pregnancy. International Journal of Molecular Sciences 2025; 26(13) doi: 10.3390/ijms26136499
|
| 5 |
Reyed M. Reyed. Advancing Personalized Medicine With AI-Driven Microbiome and Nutrigenomics. Advances in Computational Intelligence and Robotics 2026; doi: 10.4018/979-8-3373-3121-8.ch001
|
| 6 |
Behshad Boroumand, Amirhossein Jaberi, Ghazal Zamani, Ehsan Zandi, Farshad Zare, Milad Vahedinezhad, Elham Abdollahi, Sepideh KarkonShayan, Sasan GhazanfarAhari, Mustafa Sattar. Therapeutic Remodeling of the Gut Microbiome as a Strategy to Restore Immune Tolerance in Autoimmunity. MicrobiologyOpen 2026; 15(2) doi: 10.1002/mbo3.70294
|
| 7 |
Jian Hou, Liqun Shang, Zi Yan, Yuanhan Ao, Wanying Chen, Pei Lin, Jiarui Liu, Xintong Wang, Zhaojin Li, Huayang Li, Quan Liu, Yi Zhang, Jianping Yao, Can Gao, Junyou Zhu, Shiyu Li, Suiqing Huang, Zhongkai Wu. VSIG3 preserves mitochondrial homeostasis and restrains CD4⁺ T-Cell infiltration in myocardial ischemia–reperfusion injury through regulation of mitochondrial-derived vesicles. Journal of Nanobiotechnology 2026; 24(1) doi: 10.1186/s12951-026-04766-8
|
| 8 |
Simiao Chen, Lu Wang, Shuotong Zhang, Jun Zhang, Xin Yan, Zhongming Wu. Probiotics in type 1 diabetes: immunomodulatory mechanisms and the unresolved question of clinical efficacy. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1931902
|
| 9 |
Eugenio Cavalli, Giuseppe Rosario Pietro Nicoletti, Ferdinando Nicoletti. A Historical and Epistemological Review of Type 1 Diabetes Mellitus. Journal of Clinical Medicine 2025; 14(14) doi: 10.3390/jcm14144923
|
| 10 |
Tinglin Lu, Weidong Qiang, Qingqing Ye. Cytokines and chemokines in diabetes: Immunopathogenesis, therapeutic targets, and future perspectives across all disease forms. Pathology - Research and Practice 2026; 282 doi: 10.1016/j.prp.2026.156466
|
| 11 |
Yunfang Wang, Jinwen Han, Zheng Wang, Gai Zhang, Ruilan Niu, Yaqing Wei, Kang Yi, Jinxing Quan. Fueling bone loss: the immunometabolic reprogramming of the bone microenvironment in diabetic osteoporosis. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1850044
|